Report of Foreign Issuer (6-k)
November 15 2016 - 12:24PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of November, 2016
Commission File Number 001-36734
CIPHER PHARMACEUTICALS INC.
(Translation of registrant’s name into
English)
2345 Argentia Road, Suite 100A
Mississauga, Ontario
L5N 8K4
(905) 602-5840
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F
o
Form 40-F
x
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1):
o
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7):
o
EXHIBIT INDEX
|
99.1
|
|
News
Release dated November 11, 2016 - Cipher Pharmaceuticals Reports Q3 2016 Financial Results
|
2
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
Date: November 11, 2016
|
|
CIPHER PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
|
|
|
|
By:
|
/s/ Stephen Lemieux
|
|
|
|
Stephen Lemieux
|
|
|
|
Chief Financial Officer
|
3
Cipher Pharmaceuticals (QX) (USOTC:CPHRF)
Historical Stock Chart
From Oct 2024 to Nov 2024
Cipher Pharmaceuticals (QX) (USOTC:CPHRF)
Historical Stock Chart
From Nov 2023 to Nov 2024
